Total Payments
$29,229
2024 Payments
$1,402
Companies
46
Transactions
1,549
Medicare Patients
1,903
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$29,017 (99.3%)
Education$149.16 (0.5%)
Gifts$63.15 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,017 | 1,516 | 99.3% |
| Education | $149.16 | 32 | 0.5% |
| Gift | $63.15 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,139 | 235 | $0 (2024) |
| PFIZER INC. | $3,927 | 300 | $0 (2024) |
| Amgen Inc. | $2,904 | 127 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $2,726 | 82 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,273 | 117 | $0 (2024) |
| Janssen Biotech, Inc. | $1,628 | 102 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $1,352 | 81 | $0 (2019) |
| Celgene Corporation | $1,258 | 74 | $0 (2019) |
| UCB, Inc. | $1,187 | 72 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,130 | 65 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,402 | 74 | Mallinckrodt Hospital Products Inc. ($259.45) |
| 2023 | $2,691 | 117 | Mallinckrodt Hospital Products Inc. ($478.57) |
| 2022 | $4,327 | 205 | ABBVIE INC. ($861.09) |
| 2021 | $3,785 | 182 | Mallinckrodt Hospital Products Inc. ($839.90) |
| 2020 | $3,925 | 214 | AbbVie Inc. ($758.90) |
| 2019 | $4,842 | 296 | AbbVie, Inc. ($874.92) |
| 2018 | $4,688 | 255 | Novartis Pharmaceuticals Corporation ($516.99) |
| 2017 | $3,569 | 206 | AbbVie, Inc. ($728.21) |
All Payment Transactions
1,549 individual payment records from CMS Open Payments — Page 3 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Immunology | ||||||
| 03/21/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation | ||||||
| 02/26/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Education | In-kind items and services | $20.03 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 02/21/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Inflammation | ||||||
| 02/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Dermatology | ||||||
| 02/08/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Inflammation | ||||||
| 02/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Education | In-kind items and services | $20.03 | General |
| Category: Immunology | ||||||
| 01/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Dermatology | ||||||
| 01/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 01/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 01/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Dermatology | ||||||
| 01/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Dermatology | ||||||
| 12/22/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 75 | 77 | $10,146 | $3,032 |
| 2022 | 12 | 547 | 33,916 | $3.6M | $729,856 |
| 2021 | 13 | 571 | 33,756 | $4.6M | $933,366 |
| 2020 | 16 | 710 | 32,055 | $4.8M | $1.0M |
Total Patients
1,903
Total Services
99,804
Medicare Billing
$2.7M
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 20551 | Injections of tendon attachment to bone | Office | 2021 | 12 | 18 | $3,420 | $279.18 | 8.2% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2020 | 18 | 9,750 | $1.3M | $420,212 | 33.2% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2020 | 25 | 9,110 | $2.2M | $365,803 | 16.4% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2020 | 12 | 11,350 | $959,075 | $179,976 | 18.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 318 | 587 | $76,310 | $29,443 | 38.6% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 36 | 187 | $112,200 | $20,473 | 18.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 29 | 192 | $40,320 | $10,705 | 26.6% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2020 | 33 | 236 | $30,680 | $5,581 | 18.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 37 | 58 | $15,125 | $2,836 | 18.8% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2020 | 29 | 161 | $10,948 | $2,044 | 18.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,100 | $1,857 | 36.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2020 | 29 | 148 | $2,960 | $729.00 | 24.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 57 | 171 | $1,710 | $711.06 | 41.6% |
| 20551 | Injections of tendon attachment to bone | Office | 2020 | 22 | 30 | $5,700 | $604.29 | 10.6% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 17 | 27 | $5,805 | $538.02 | 9.3% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2020 | 16 | 16 | $2,400 | $365.33 | 15.2% |
| 72170 | X-ray of pelvis, 1 or 2 views | Office | 2020 | 15 | 15 | $1,950 | $250.07 | 12.8% |
About Dr. Sandra Hoffmann, M.D
Dr. Sandra Hoffmann, M.D is a Rheumatology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477565893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Hoffmann, M.D has received a total of $29,229 in payments from pharmaceutical and medical device companies, with $1,402 received in 2024. These payments were reported across 1,549 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($29,017).
As a Medicare-enrolled provider, Hoffmann has provided services to 1,903 Medicare beneficiaries, totaling 99,804 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Saint Louis, MO
- Active Since 08/13/2006
- Last Updated 09/29/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1477565893
Products in Payments
- ACTHAR (Biological) $4,078
- XELJANZ (Drug) $3,740
- Enbrel (Biological) $1,912
- COSENTYX (Biological) $1,770
- RINVOQ (Biological) $1,462
- Humira (Biological) $1,365
- Cimzia (Drug) $1,187
- BENLYSTA (Biological) $1,005
- ORENCIA (Biological) $914.88
- Otezla (Drug) $822.44
- TALTZ (Drug) $664.80
- TREMFYA (Drug) $638.13
- RINVOQ (Drug) $491.21
- KEVZARA (Drug) $479.20
- SIMPONI ARIA (Biological) $445.37
- Rinvoq (Biological) $441.62
- REMICADE (Biological) $391.34
- SAPHNELO (Biological) $368.41
- STELARA (Biological) $360.95
- HUMIRA (Biological) $349.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Saint Louis
Dr. Alfred Kim, Md, MD
Rheumatology — Payments: $402,454
Rheumatology $402,454
Dr. Sona Kamat, M.d, M.D
Rheumatology — Payments: $266,392
Rheumatology $266,392
Dr. Adam Kilian, M.d, M.D
Rheumatology — Payments: $259,162
Rheumatology $259,162
Dr. Benjamin Schwartz, Md, MD
Rheumatology — Payments: $145,337
Rheumatology $145,337
Akgun Ince, M.d, M.D
Rheumatology — Payments: $55,223
Rheumatology $55,223
Dr. John Budd, Md, MD
Rheumatology — Payments: $27,292
Rheumatology $27,292